Company Profile

Apollo Endosurgery, Inc. is a medical technology company, which is focused on the development of medical devices to advance gastrointestinal therapeutic endoscopy. The Company develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The Company's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

06/23/06	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P TMI Index	CI
06/23/06	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P Global BMI Index	CI

06/23/06	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P TMI Index	CI
06/23/06	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P Global BMI Index	CI
04/23/04	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from NASDAQ Composite Index	CI
04/23/04	Boston Scientific Corporation completed the acquisition of Apollo Endosurgery, Inc. from a group of shareholders.	CI
23/23/23	Cowen Downgrades Apollo Endosurgery to Market Perform From Outperform, Adjusts Price Target to $10 From $13	MT
04/23/04	Stifel Downgrades Apollo Endosurgery to Hold From Buy, Price Target is $10	MT
30/22/30	Lake Street Downgrades Apollo Endosurgery to Hold From Buy, Adjusts Price Target to $10 From $14	MT
30/22/30	Sector Update: Health Care Stocks Unable to Complete Tuesday Recovery	MT
30/22/30	Top Midday Gainers	MT
29/22/29	Apollo Endosurgery Shares Hit 52-Week High on Boston Scientific Deal	DJ
29/22/29	Boston Scientific Strikes $615 Million Deal to Buy Medical Tech Firm Apollo Endosurgery	MT
29/22/29	Easing Concerns Over China COVID-19 Protests Prompt Quiet Premarket Session for US Equities	MT
29/22/29	Top Premarket Gainers	MT

23/23/23	Cowen Downgrades Apollo Endosurgery to Market Perform From Outperform, Adjusts Price Target to $10 From $13	MT
04/23/04	Stifel Downgrades Apollo Endosurgery to Hold From Buy, Price Target is $10	MT
30/22/30	Lake Street Downgrades Apollo Endosurgery to Hold From Buy, Adjusts Price Target to $10 From $14	MT
04/22/04	Stephens Adjusts Apollo Endosurgery's Price Target to $9 from $8, Keeps Overweight Rating	MT
23/22/23	Stifel Nicolaus Adjusts Apollo Endosurgery Price Target to $10 From $12, Maintains Buy Rating	MT

04/23/04	APOLLO ENDOSURGERY, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, (form 8-K)	AQ
31/23/31	APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
10/23/10	Apollo Endosurgery : Submission of Matters to a Vote of Security Holders - Form 8-K	PU
10/23/10	APOLLO ENDOSURGERY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
30/22/30	APOLLO ENDOSURGERY, INC. : Unregistered Sale of Equity Securities (form 8-K)	AQ

Manager	Title	Age	Since
Christopher J. Gostout CTO	Chief Tech/Sci/R&D Officer	75	01/01/2017
Thomas Neudeck CTO	Chief Tech/Sci/R&D Officer	-	-
Tiffanie Gilbreth CTO	Chief Tech/Sci/R&D Officer	-	-

Lpath, Inc. Share Price Nasdaq

Stocks

US5489103060

Medical Equipment, Supplies & Distribution

Latest news : Lpath, Inc.

Analysts' recommendations: Lpath, Inc.

Press Releases: Lpath, Inc.

News in other languages: Lpath, Inc.

Managers and Directors: Lpath, Inc.

Medical Equipment

Company Profile

Director	Title	Age	Since
Vance Brown BRD	Director/Board Member	57	04/04/2023
Jonathan Monson BRD	Director/Board Member	52	04/04/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PENUMBRA, INC.	-0.94%	-0.92%	+26.61%	+28.88%	1.28TCr
GETINGE AB	-1.06%	+1.46%	+18.83%	+33.52%	707.3Cr
ASAHI INTECC CO., LTD.	-1.96%	+4.36%	+53.35%	+47.77%	689.23Cr
MINIMED GROUP, INC.	-0.20%	+0.80%	-	-	566.74Cr
APT MEDICAL INC.	+16.51%	+22.40%	-6.39%	+88.91%	551.07Cr
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+1.51%	-2.27%	-27.43%	-22.00%	389.87Cr
NOVOCURE LIMITED	-2.36%	+2.24%	+50.85%	-42.77%	206.92Cr
NAKANISHI INC.	-2.10%	-7.62%	+44.08%	-11.01%	161.91Cr
IMPLANTICA AG	+10.70%	+14.78%	-19.95%	+144.58%	162.05Cr
Average	+2.19%	+2.82%	+17.49%	+33.48%	523.37Cr
Weighted average by Cap.	+1.51%	+3.46%	+20.33%	+35.40%

End-of-day quote Nasdaq
- ^USD	-